Karyopharm Therapeutics (25K0.F) Q3 2025 Earnings

11AugConfirmed
Q1 2025
Q2 2025
Q3 2025
-3.98
-3.49
-2.99
-2.5

Details

Expected EPS
-3.51394793697
Actual EPS
-3.7191312
Surprise EPS
-0.21
Surprise Percent
+5.84%

Description

Karyopharm Therapeutics (25K0.F) has reported earnings of -3.7191312 per share for Q3 2025.

0 Comments

Share your thoughts